Article
Nuclear Receptor RORα/γ: Exciting Modulators in Metabolic Syndrome and Related Disorders
21 Jun 2022
Abstract excerpt
Under the influences of modern lifestyle, metabolic syndromes (MetS), including insulin resistance, obesity, and fatty liver, featuring a worldwide chronic disease, greatly raise the risk of type 2 diabetes, heart disease, and stroke. However, its pathogenesis is still unclear, and there are limited drugs with strong clinical efficacy and specificity. Given the close connection between impaired lipid metabolism...